|
|
| | Tesnatilimab Basic information |
| Product Name: | Tesnatilimab | | Synonyms: | Tesnatilimab;Research Grade Tesnatilimab (DHD72101);Tesnatilimab (anti-NKG2D);IPH-23XX|||JNJ-64304500|||JNJ 4500;Research Grade Tesnatilimab | | CAS: | 2242758-08-1 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Tesnatilimab Structure]() |
| | Tesnatilimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Tesnatilimab Usage And Synthesis |
| Uses | Tesnatilimab is a human IgG4 monoclonal antibody that acts on the immune activating receptor NKG2D and has potential immunomodulatory and anti-inflammatory activity. Tesnatilimab can be used in the study of inflammatory bowel disease (IBD)[1][2]. | | References | [1] Kasper Vadstrup, et al. Anti-NKG2D mAb: A New Treatment for Crohn's Disease Int J Mol Sci. 2017 Sep 16;18(9):1997. DOI:10.3390/ijms18091997
[2] Wei L, et al. The role of NKG2D and its ligands in autoimmune diseases: new targets for immunotherapy[J]. International Journal of Molecular Sciences, 2023, 24(24): 17545. DOI:10.3390/ijms242417545 |
| | Tesnatilimab Preparation Products And Raw materials |
|